Second-line CAR T-Cell Treatment in Diffuse Large B-cell Lymphoma (DLBCL)

Author:

avatar

Prof. Dr Christoph Renner

Specialist in Medical Oncology
Haematology and General Internal Medicine Onkozentrum Hirslanden
Klinik Hirslanden
Zurich, Switzerland

Begin Module